DSIP

Research

Delta Sleep-Inducing Peptide

Category
Sleep & Recovery
Aliases
Wagner-Jurgens peptide
Administration
Subcutaneous injection (research), Intranasal (research)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Some users report feeling calmer, though a clear improvement in sleep itself is not consistently observed.

  2. 2

    3–4 Weeks

    Continued use is generally associated with a subtle, if any, additional felt change.

  3. 3

    5–7 Weeks

    Available research does not support a strong cumulative effect building over this period.

  4. 4

    8–10 Weeks

    Most users do not report a distinctly different experience at this stage compared to earlier use.

  5. 5

    11–15 Weeks

    Long-term felt effects have not been well characterized in available research.

  6. 6

    16–20 Weeks

    No well-established human timeline exists to reference at this stage.

  7. 7

    21–24 Weeks

    This duration exceeds most historical research use patterns documented for this compound.

⚠️ Research context only. This is not medical advice and results are not guaranteed.